Marinobufagenin as a Target for DIGIBIND in Preeclampsia

CompletedOBSERVATIONAL

Enrollment

144

Participants

Timeline

Start Date

August 16, 2006

Study Completion Date

July 29, 2014

Conditions

Preeclampsia

Trial Locations (3)

City Hospital No. 9, Saint Petersburg

Pushlon Hospital, Saint Petersburg

Veevolozhsk Hospital, Saint Petersburg

All Listed Sponsors

lead

National Institute on Aging (NIA)

NIH

NCT01328600 - Marinobufagenin as a Target for DIGIBIND in Preeclampsia | Biotech Hunter | Biotech Hunter